Anthropic Launches AI Drug Discovery Program Targeting Neglected Diseases

Anthropic announced an internal drug discovery program at an event in San Francisco on Tuesday, with the AI company's life sciences head Eric Kauderer-Abrams stating the initiative will focus on treatments for neglected diseases. The program is designed to develop artificial intelligence tools for drugmakers as part of Anthropic's Claude Science product strategy. Tech giants including Alphabet, Apple, and Amazon have previously entered the healthcare market with mixed results, making Anthropic the latest major technology company to target the pharmaceutical industry.

Anthropic Focuses on Neglected Diseases and Industry Partnership

Kauderer-Abrams said at the San Francisco event on Tuesday that Anthropic will concentrate on discovering treatments for diseases that traditional biopharmaceutical companies wouldn't consider attractive targets. "We're doing this because we believe first and foremost that to build the right models, products and tools to accelerate the industry, we need to live it along with all of you," Kauderer-Abrams said. "We believe in the power of tight feedback loops, and there's no substitute for having our own experiences alongside you all in the trenches trying to develop drugs."

Kauderer-Abrams did not specify what Anthropic would do if it finds promising drug candidates. Jonah Cool, Anthropic's head of life sciences partnerships, said Anthropic's goal is to focus on neglected diseases as it creates and sells AI tools for life sciences companies. Kauderer-Abrams and other Anthropic leaders positioned the effort as a way to work alongside the drugmakers the company is trying to court for its Claude Science product.

Tech Giants Pursue Healthcare Market with Varied Approaches

Tech giants have long taken aim at healthcare, though with mixed results. Alphabet and Apple have jumped into the market in various ways, and Amazon has built a business in healthcare through its acquisitions of One Medical and PillPack, now housed in a division called Amazon Health Services.

FAQ

What did Anthropic announce on Tuesday? Anthropic announced an internal drug discovery program at an event in San Francisco on Tuesday, with life sciences head Eric Kauderer-Abrams stating the initiative will focus on treatments for neglected diseases that traditional biopharmaceutical companies wouldn't consider attractive targets.

Why is Anthropic launching a drug discovery program? According to Eric Kauderer-Abrams, Anthropic is launching the program to build better AI models, products, and tools for the pharmaceutical industry by experiencing the drug development process firsthand alongside drugmakers, as part of its Claude Science product strategy.